Maravai LifeSciences Holdings, Inc. Class A (MRVI) Dividend History

Maravai LifeSciences Holdings, Inc. Class A (MRVI) is a biotechnology company that provides essential products and technologies used in life sciences research, vaccine development, and diagnostics. The company specializes in the production of nucleic acid-based reagents, including mRNA, for pharmaceutical and research applications. Maravai focuses on supporting the global healthcare industry through its innovative solutions and scalable manufacturing capabilities.

10770 Wateridge Circle Suite 200, San Diego, CA, 92121
Phone: (858) 546-0004
Website: https://www.maravai.com

Dividend History

Maravai LifeSciences Holdings, Inc. Class A currently does not pay dividends

Company News

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (MRVI) for alleged violations of federal securities laws, including inaccurate revenue recognition and overstated goodwill.

GlobeNewswire Inc.
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Investors who purchased Maravai LifeSciences Holdings, Inc. securities between August 7, 2024 and February 24, 2025 are encouraged to join a class action lawsuit against the company for alleged securities fraud violations.

Benzinga
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 – MRVI

Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. of a class action securities lawsuit related to alleged securities fraud between August 7, 2024 and February 24, 2025.

GlobeNewswire Inc.
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Maravai LifeSciences Holdings, Inc. (MRVI) is facing a class action lawsuit alleging the company made materially false and/or misleading statements about its financial reporting, revenue recognition, and goodwill.

GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. has filed class action lawsuits against AppLovin, Maravai, e.l.f. Beauty, and Skyworks Solutions, alleging various financial irregularities and misleading statements by the companies.

GlobeNewswire Inc.

Featured Companies: APP ELF SWKS

Dividend data last updated 06/07/2025 18:00:04 UTC